Early myeloid-derived suppressor cells accelerate epithelial-mesenchymal transition by downregulating ARID1A in luminal A breast cancer.

Early myeloid-derived suppressor cells accelerate epithelial-mesenchymal transition by downregulating ARID1A in luminal A breast cancer.
复制标题

早期骨髓源性抑制细胞通过下调 Luminal A 乳腺癌中的 ARID1A 来加速上皮间质转化。

DOI:
10.3389/fbioe.2022.973731
复制
发表时间:
2022
影响因子:
5.7
通讯作者:
Yu, Jinpu
Yu, Jinpu
中科院分区:
工程技术2区
文献类型:
--
作者:
Chen, Guidong;Li, Xingchen;Ji, Chenyan;Liu, Pengpeng;Zhou, Li;Xu, Dechen;Wang, Dong;Li, Jie;Yu, Jinpu

文献摘要

参考文献

被引文献

相似文献

Early myeloid-derived suppressor cells (eMDSCs) are a newly characterized subclass of MDSCs, which exhibit more potent immunosuppressive capacity than classical MDSCs. Previously, we found high eMDSCs infiltration was correlated with poor prognosis of breast cancer, though the regulatory mechanisms have not been fully understood. Here, we constructed a 21-gene signature to evaluate the status of eMDSCs infiltration within breast cancer tissues and found that highly infiltrated eMDSCs affected the prognosis of breast cancer patients, especially in luminal A subtype. We also found that eMDSCs promoted epithelial-mesenchymal transition (EMT) and accelerated cell migration and invasion in vitro. Meanwhile, eMDSCs significantly downregulated ARID1A expression in luminal A breast cancer, which was closely associated with EMT and was an important prognostic factor in breast cancer patients. Moreover, significant changes of EMT-related genes were detected in luminal A breast cancer cells after co-cultured with eMDSCs or ARID1A knock-down and overexpression of ARID1A significantly reversed this procedure. These results implied that eMDSCs might suppress the ARID1A expression to promote EMT in luminal A breast cancer cells, which might provide a new light on developing novel treatment regimens for relapsed luminal A breast cancer after conventional therapies.
DOI: 10.3802/jgo.2021.32.e3
发表时间: 2021-01
影响因子: 3.9
作者:
Jung US;Min KW;Kim DH;Kwon MJ;Park H;Jang HS
通讯作者: Jang HS
DOI: 10.1016/j.immuni.2021.04.004
发表时间: 2021-05-11
期刊: Immunity
影响因子: 32.4
作者:
Hegde S;Leader AM;Merad M
通讯作者: Merad M
DOI: 10.1038/ncomms1033
发表时间: 2010-07-13
影响因子: 16.6
作者:
Li, Jie;Lenferink, Anne E. G.;Deng, Yinghai;Collins, Catherine;Cui, Qinghua;Purisima, Enrico O.;O'Connor-McCourt, Maureen D.;Wang, Edwin
通讯作者: Wang, Edwin
DOI: 10.1038/ncomms12150
发表时间: 2016-07-06
影响因子: 16.6
作者:
Bronte V;Brandau S;Chen SH;Colombo MP;Frey AB;Greten TF;Mandruzzato S;Murray PJ;Ochoa A;Ostrand-Rosenberg S;Rodriguez PC;Sica A;Umansky V;Vonderheide RH;Gabrilovich DI
通讯作者: Gabrilovich DI
M2巨噬细胞衍生的外泌体促进结肠癌细胞迁移和侵袭
DOI: 10.1158/0008-5472.can-18-0014
发表时间: 2019-01-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Lan, Jingqin;Sun, Li;Wang, Guihua
通讯作者: Wang, Guihua